Elis announces two strategic acquisitions in Spain and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Elis announces two strategic acquisitions in Spain and Brazil

With Indusal in Spain and Lavebras in Brazil, Elis continues the implementation of its strategy in two key markets and increases the share of international business to over 40% of its revenues

  • Two countries with high potential
    • Elis will become the sector leader in Spain and consolidate its leading position in Brazil, [1]  with a market share above 25% in both countries
    • Fragmented markets with low outsourcing ratios
    • Excellent growth track-record for Elis in these markets (both in terms of revenues and margin)
  • Total investment for these acquisitions amounts to around €510m
    • Indusal: investment of €170m, corresponding to a multiple of 5x 2016e EBITDA post-synergies
    • Lavebras: investment of R$1,230m (c.€340m [2] ), corresponding to a multiple of 8x 2016e EBIT post-synergies [3]
  • Optimized financing and capital increase
    • €550m bridge financing
    • €325m capital increase with preferential subscription rights, with support from Eurazeo and Crédit Agricole Assurances
    • €1,150m senior loan refinancing (from €850m today), with a maturity extended to 2022 and an improvement of margin grid by c.50bps
  • Significant value creating operations
    • Between €25m and €30m of synergies by 2019, excluding tax credit [4]
    • 30% target EBITDA margin by 2019 in both countries [5]
    • c.7% accretive impact on adjusted EPS expected in FY2017 [6]

Saint-Cloud, December 21, 2016 - Elis, the leading multi-services group in Europe and Latin America, specializing in the rental and maintenance of professional clothing, textile articles, hygiene and wellbeing appliances, announces the strengthening of its positions in two of its key geographies with the completion of the acquisition of Compañia Navarra de Servicios Integrales SL ("Indusal") in Spain and a memorandum of understanding for the acquisition of Lavebras Gestão de Têxteis S.A. ("Lavebras") in Brazil.

Commenting on this announcement, Xavier Martiré, Elis's CEO , said:

"The acquisitions of Indusal in Spain and Lavebras in Brazil are a decisive step in Elis's international expansion in Spain and Brazil, two countries that have been the main drivers of the Group's organic growth for the past 2 years. In Spain, Elis will become the leader in a market experiencing strong growth and the Group will thus have access to an extended network covering the whole country. In Brazil, Elis will consolidate its leading position on a priority market, thanks to its potential for both revenue growth and margin improvement. With the acquisition of these two major players in markets that are key for its international expansion, Elis secures two significant levers for value creation and strengthens the Group's organic growth profile and potential earnings improvement, while at the same time delivering to its shareholders transactions that will have an accretive impact on earnings per share as early as 2017. By indicating their intention to subscribe to the capital increase pro rata their stakes, Eurazeo and Crédit Agricole Assurances, our two main shareholders, have again demonstrated their confidence in the Group's strategy."

Transactions' rationale

  • Elis will become the sector leader in Spain and consolidate its leading position in Brazil
  • Strengthening of the Group's growth profile in two strategic markets
    • Strong growth track-record of Elis in these markets
      • Double digit organic growth for Elis in Spain since 2014 (notably +14% over the first nine months of 2016)
      • Double digit organic growth for Elis in Brazil since 2015, despite challenging macroeconomic conditions (notably +14% over the first nine months of 2016)
    • Two markets with high growth potential
      • Organic growth as local outsourcing is still limited
        • Spanish market size estimated at only 600 million euros (as of 2014) compared to 2.0 billion euros for France [7]
        • Brazilian market size estimated at only 900 million euros [7]   (as of 2014)
      • External growth with additional bolt-on opportunities
  • Margin improvement:
    • Margins progressing although currently below Group average
    • Network densification will lead to significant productivity gains

Presentation of the acquisitions

Indusal (Spain)

A family-owned business founded in 1981, Indusal is the #2 sector player in Spain (just ahead of Elis). Indusal is a player in the linen rental and laundering sector, well-positioned in the hospitality, healthcare and industry segments. Indusal operates 24 plants and has around 1,450 employees [8] . Indusal's revenues are expected to reach c.90 million euros in 2016, with an EBITDA margin of c.27%. This acquisition will enable Elis to double its revenues in Spain and become the leading player, with a market share above 25% on a buoyant market with a fragmented competitive landscape.

Lavebras (Brazil)

Lavebras, #2 on the Brazilian market behind Elis, is present in 17 states in Brazil and has around 4,000 employees [9] in 76 plants. A family-owned company established in 1997, Lavebras owns the densest industrial laundry complex in Brazil. The Lavebras Group operates in the healthcare, industry (agribusiness notably) and hospitality segments. In 2016, Lavebras's revenues are expected to exceed 370 million reals (103 million euros) with an EBITDA margin above 30% and an EBIT margin of c.19%. Lavebras's activity has grown substantially both organically and through external growth with 12 acquisitions completed since 2015. Non-rented linen ("laundered linen") accounts for half of Lavebras's revenues (vs. less than 10% for Elis at group level), which is specific to the Brazilian market. The requirement of capital expenditure on "laundered linen" activities is lower [10] than for rented linen activities and thus accounts for Lavebras's lower capital intensity compared to the Group. With Lavebras, Elis will consolidate its position as the leading player in Brazil, with a market share above 25%.    Invested amount

Total investment for these acquisitions amounts to around 510 million euros:

  • 170 million euros for the acquisition of 100% of Indusal 's capital, corresponding to a multiple of  7x 2016e EBITDA pre-synergies and 5x 2016e EBITDA post-synergies.
  • 1,230 million reals (c.340 [11] million euros) for the acquisition of 100% of Lavebras net of the amount reinvested by DNA Capital in the new combined Brazilian entity (70 million reals, around 20 million euros). DNA Capital, Lavebras's historical shareholder and the investment vehicle for the Bueno family (with investments in healthcare companies such as DASA and Amil) thus demonstrates its confidence in the new structure. This amount values Lavebras at an implied multiple of 18x 2016e EBIT pre-synergies and 8x 2016e EBIT post-synergies [12] .

                     Financing of the acquisitions

  • The financing for these acquisitions has been secured through a 550 million euro bridge loan signed in early November 2016 with a syndicate of international banks.
  • The refinancing of this bridge loan will combine:
    • A new syndicated loan  in a principal amount of 1,150 million euros to refinance Elis's current senior loan along with the outstanding amount due on the bridge loan: Elis has received commitments from a pool of 15 leading international banks to refinance Elis's senior loan, with an extension of the maturity (January 2022 vs. February 2020 for the existing senior loan), an increased principal amount (1,150 million euros vs. 850 million euros for the existing senior loan) and a margin grid improvement of c.50 basis points. Final documentation for this new syndicated loan is expected be signed in January 2017.
    • A capital increase with preferential subscription rights  in an amount of c.325 million euros with a view to restoring Elis's leverage ratio to around 3.0x EBITDA post transactions. Eurazeo and Crédit Agricole Assurances, the two major shareholders, with stakes of 16.9% [13]  and 10% respectively, have indicated that they intend to fully take-up their rights, i.e. a combined amount of around 87 million euros. The rights issue is expected to occur during the first half of 2017, subject to favourable market conditions.

Value creation 

Both transactions are expected to generate significant synergies that will lead to improved operating margins:

  • Estimated synergies per year to fully materialise by 2019:
    • c.10 million euros in Spain, of which 90% are cost synergies (derived from centralized purchasing of linen and consumables and industrial optimization, among others) and 10% are topline synergies.
    • c.60 million reals (17 million euros) in Brazil, of which 67% are cost synergies (centralized purchasing of linen and consumables, industrial optimization) and 33% are topline synergies (derived from revenue efficiency improvement, among others).
    • In addition, in Brazil, tax credit of c.300 million reals (c.83 million euros), representing tax goodwill expected to be amortized over 5 years.
  • 30% target EBITDA margin by 2019 in both countries. [14]

Two strategic acquisitions with an accretive impact on adjusted earnings per share as early as 2017

The acquisitions of Indusal and Lavebras improve substantially the Group's growth and earnings profile, boosted by (i) the organic growth contribution resulting from the two acquisitions, (ii) the expected synergies with the Group and (iii) the margin improvement dynamics following the increased size of the Group in these two geographies. Following these transactions, the share of international business in the Group's total revenues is expected be over 40% [15] (from 25% in 2014). These two transactions will have an accretive impact on adjusted earnings per share post refinancing of around 7% in FY2017. [16]

Completion of the acquisitions

The acquisition of Indusal closed on the signing date of the agreement.

Pursuant to the memorandum of understanding entered into by Elis, the definitive agreements for the acquisition of Lavebras will be executed in early January. The completion of the acquisition of Lavebras remains subject to the approval of the Brazilian competition authority. This acquisition is expected to close during the first half of 2017.

Contact

Nicolas Buron , Investor Relations Director - Phone: +33 1 75 49 93 93 - nicolas.buron@elis.com

Investor and analyst conference call

Speakers: Xavier Martiré, CEO Louis Guyot, CFO

Date: Thursday, December 22, 2016 09:15 am Paris time - 08:15 am London time Webcast link (live and replay): http://edge.media-server.com/m/p/d2i7o9de Webcast replay will be available for 1 year following the event.

Dial-in numbers: France: +33 1 76 77 22 20 France (toll-free): 0805 631 580   United Kingdom: +44 203 427 1902 United Kingdom (toll-free): 0800 279 5004 Code: 2873371

Replay numbers: France: +33 1 74 20 28 00 United Kingdom: +44 203 427 0598 Code for replay: 2873371 The audio replay will be available for one week following the event.

Financial definitions       

  • Organic growth in the Group's revenue is calculated excluding (i) the impacts of changes in the scope of consolidation of "major acquisitions" and "major disposals" in each of the periods under comparison, as well as (ii) the impact of exchange rate fluctuations.
  • EBITDA is defined as EBIT before depreciation and amortization net of the portion of grants transferred to income. EBITDA is a performance measure presented in the Group's consolidated financial statements.
  • EBITDA margin is defined as EBITDA divided by revenues.
  • EBIT is defined as net income (loss) before net financial expense, income tax, share in income of equity-accounted companies, amortization of customer relationships, goodwill impairment, other income and expense and miscellaneous financial items (bank fees recognized in operating income).
  • Adjusted earnings per share (EPS) for the FY2015 means earnings attributable to shareholders of the parent company, adjusted for impairment charge, PPA depreciation and IPO and refinancing expenses (net of tax)and divided by the weighted average number of ordinary shares. Adjusted earnings per share (EPS) for the FY2017 means earnings attributable to shareholders of the parent company, adjusted for exceptional items and divided by the number of ordinary shares outstanding post completion of the rights issue. The adjusted earnings per share for the FY2017 are calculated based on the integration of Lavebras and Indusal as of January 1, 2017 and expected synergies for 2017.

Disclaimer

Elis draws the public's attention to the risk factors described in Chapter 2 of the registration document of Elis S.A. ("Elis"), registered with the Autorité des marchés financiers ("AMF") under n° R.16-019 on 13 April 2016 (the "Registration Document"), which is available from the AMF's website at www.amf-france.org and from Elis's website at www.corporate-elis.com , which should be carefully considered before making any investment decision. The materialization of all or any of these risks may have an adverse effect on the Group's operations, financial conditions, results or objectives, or the market price of Elis shares.

Neither this press release, nor any information it contains or other information related to these transactions or to Elis, may be transmitted to the public in a country in which any approval or registration is required. No steps to such end have been taken or will be taken by Elis in any country in which such steps would be required (other than France).

This press release does not constitute an offer or a solicitation to sell or subscribe requiring a prospectus within the meaning of Directive 2003/71/CE of the European Parliament and Council dated 4 November 2003, as amended, in particular by Directive 2010/73/UE in the case where such directive was implemented into law in the member States of the European Economic Area (together, the "Prospectus Directive").

Any public offering of Elis securities may be made only in France and only pursuant to a prospectus having received the visa of the AMF. With respect to the member States of the European Economic Area other than France (the "Member States") having implemented the Prospectus Directive into law, no action has been or will be taken in order to permit a public offer of the securities which would require the publication of a prospectus in one of such Member States. In Member States other than France, this press release and any offer if made subsequently are directed exclusively at persons who are "qualified investors" and acting for their own account within the meaning of the Prospectus Directive and any relevant implementing measures in the relevant Member State.

This press release may not be published, released, transmitted or distributed, directly or indirectly, in the United States of America, Canada, Australia or Japan. Neither this press release nor any information it contains constitutes an offer of securities nor a solicitation for purchase, subscription or sale of securities in any such country.

The release, publication or distribution of this press release in certain jurisdictions may be restricted by laws or regulations. Therefore, persons in such jurisdictions into which this document is released, published or distributed must inform themselves about and comply with such laws or regulations.

This press release and the information it contains are not released and may not be published, released or distributed in or into the United States. This press release does not constitute or form part of an offer of securities or a solicitation for purchase, subscription or sale of securities in the United States. The securities referred herein have not been nor will be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") and may not be offered, subscribed or sold in the United States without registration under the U.S. Securities Act, or pursuant to an exemption from registration. Elis does not intend to undertake any public offering of its securities in the United States.

In the United Kingdom, this press release is directed only at "qualified investors" (as defined in section 86(7) of the Financial Services and Markets Act 2000) who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) persons falling within Article 49(2) (a) to (d) of the Order (high net worth entities, non-registered associations, etc.) (all such persons being referred to as "Relevant Persons"). This press release is directed only at Relevant Persons. Any investment or investment activity applies to, and may only be made by, Relevant Persons.

This press release includes certain statements of forecasts and trends that are based on current data, assumptions and expectations that may evolve or be revised due to uncertainty related, among other factors, to known and unknown business risks and the economic, financial, competitive, regulatory and climatic environment in which Elis operates, as well as the Group's ability to integrate Indusal and Lavebras successfully and to achieve related synergies. Elis expressly declines any obligation or undertaking to update or revise any objectives, forecasts or other forward-looking statements made in this press release, except as required by applicable law or regulation. Elis cannot guarantee that any of the objectives described in this press release will be achieved.

This press release includes market and competition data relating to the Group. Some of these data were obtained from external market research. Such publicly available information, which Elis deems reliable, has not been independently verified and Elis cannot guarantee that a third-party using different fact-gathering, analytical or calculation methods to compute market data would obtain the same results.. Unless otherwise stated, information included in this press release relating to market shares and market size in Elis's core markets are based on Elis's management's estimates. All such data and forecasts are included herein for information purposes only.

Historical data related to Indusal and Lavebras included in this press release were furnished by Indusal and Lavebras, respectively, to Elis in connection with the acquisitions described herein. Estimated data related to Indusal and Lavebras are based on information made available to Elis by Indusal and Lavebras, respectively, as adjusted based on current estimates and hypotheses deemed reasonable by Elis's management. All data related to Indusal and Lavebras, as well as estimated financial data related to the Group, have been neither audited nor reviewed by Elis's auditors.

[1] Following execution of the definitive agreements, completion of the acquisition of Lavebras will remain subject to Brazilian antitrust clearance.

[2] Reference exchange rate of 3.6 reals for 1.0 euro

[3] Based on deducting the present value of expected tax goodwill amortization from the enterprise value of BRL1,300m

[4] For more information on synergies, see "Value Creation" below

[5] The Group's EBITDA margin ratio in 2015 was 31.5%

[6] The adjusted EPS for the FY2015 was 0.67 euro

[7] Source: KPMG, August 2014

[8] As of June 30, 2016

[9] As of July 2016

[10] Level of capital expenditure on "laundered linen" activities around 13% of Lavebras revenues vs. c.18% for Elis at group level

[11] Reference exchange rate of 3.6 reals for 1.0 euro

[12] Based on deducting the present value of expected tax goodwill amortization from the enterprise value of BRL1,300m.

[13] Of which 16.1% held via Legendre Holding 27, a company controlled by Eurazeo

[14] The Group's EBITDA margin ratio in 2015 was 31.5%

[15] Calculated based on the Group's, Indusal's and Lavebras's estimated consolidated revenues for 2016

[16] The adjusted EPS for the FY2015 was 0.67 euro

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...b169e0ac86

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 112

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 164

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 175

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Floating Solar Gets a Serious Test in Central New York

Updated Category News Views 120

A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...

Continue Reading
Hexaware’s Seven-Year Client Signal Is Worth Watching

Updated Category News Views 129

Seven straight years of recognition is harder to shrug off than one shiny plaque on a corporate shelf. Hexaware Technologies announced on November 18, 2026 that it received the ISG Star of Excellence Award in the Client Champion category, marking its seventh consecutive year of recognition in that awards program. For investors following IT services, that is a...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 16

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading
Workday GO for Financials Targets the Messy Middle

Updated Category News Views 83

Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 69

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 197

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 228

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from Key Shareholder Meetings: Tech and Industry Leaders

Updated Category News Views 229

Shareholder Meetings on the Horizon As we move into a new reporting season, the excitement surrounding the upcoming shareholder meetings is palpable. The recent financial results indicate a strong finish to the last quarter, with many companies showcasing impressive growth despite emerging macro challenges. The period after Q4 reporting sees a shift in focus toward the...

Continue Reading
Worldline Welcomes Pierre-Antoine Vacheron as CEO

Updated Category News Views 708

Worldline Welcomes Pierre-Antoine Vacheron as CEO Worldline, a leader in digital payments, has recently announced the appointment of Pierre-Antoine Vacheron as its new Chief Executive Officer. This strategic move, effective from March 1, signals a fresh start for the company as it continues to evolve within the rapidly changing payments industry. A Seasoned Professional...

Continue Reading
Autolus Therapeutics Set to Reveal Q2 2025 Financial Insights

Updated Category News Views 219

Autolus Therapeutics to Release Financial Results Soon Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering biopharmaceutical company, is gearing up to share its financial results for the second quarter of 2025. This announcement is set for shortly before the opening of U.S. markets. As a company focusing on next-generation programmed T cell therapies, the anticipation...

Continue Reading
Brightworks Dentistry Unites Practices Under One Brand

Updated Category News Views 28

New Brand Strategy in Atlanta's Dental Scene In an era where large dental chains seem to gobble up neighborhood practices like some corporate Pac-Man, Dr. Patrice Robbins takes a refreshing turn. Her brainchild, Brightworks Dentistry, is roping in all its Atlanta bases under one banner to keep that local warmth alive. By grouping Dunwoody, Buckhead, and Downtown Atlanta...

Continue Reading
AutoNation's Analyst Coverage Sparks Interest in Key Stocks

Updated Category News Views 48

Recent Insights from Analysts on AutoNation Wall Street analysts have recently published their latest evaluations of several well-known companies, presenting a blend of ratings and insights. In this article, we’ll explore the most recent coverage initiated by leading analysts, focusing specifically on AutoNation, Inc. and other notable companies. Understanding the...

Continue Reading